Moreover, a study investigating a genetic risk-based approach in identifying women at low risk of disease has shown that BC incidence was significantly reduced in the absence of variant BRCA1, BRCA2, PALB2, ATM, or CHEK2 genes and a low polygenic risk score (hazard ratio, 0.39) [30]. This evidence concerns the gene PALB2 and breast cancer.